Didier Mayeur

2.0k total citations
50 papers, 390 citations indexed

About

Didier Mayeur is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Didier Mayeur has authored 50 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Surgery. Recurrent topics in Didier Mayeur's work include Venous Thromboembolism Diagnosis and Management (9 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer Treatment and Pharmacology (6 papers). Didier Mayeur is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (9 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer Treatment and Pharmacology (6 papers). Didier Mayeur collaborates with scholars based in France, Germany and United Kingdom. Didier Mayeur's co-authors include Florian Scotté, Christophe Tournigand, Isabelle Mahé, Virginie Lucas, Courèche Kaderbhaï, Alain Landau, Sylvain Ladoire, Isabelle Desmoulins, L. Chauvenet and Estelle Botton and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Didier Mayeur

45 papers receiving 382 citations

Peers

Countries citing papers authored by Didier Mayeur

Since Specialization

Citations

This map shows the geographic impact of Didier Mayeur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Didier Mayeur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Didier Mayeur more than expected).

Fields of papers citing papers by Didier Mayeur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Didier Mayeur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Didier Mayeur. The network helps show where Didier Mayeur may publish in the future.

Co-authorship network of co-authors of Didier Mayeur

This figure shows the co-authorship network connecting the top 25 collaborators of Didier Mayeur. A scholar is included among the top collaborators of Didier Mayeur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Didier Mayeur. Didier Mayeur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Financial toxicity and socioeconomic impact of cancer in Europe 2025 ·ESMO Open ·(unknown), (unknown), (unknown), (unknown), (unknown), Tim Lubbers, Johanna Mattson, Didier Mayeur, Renée X. de Menezes, Jochen Schmitt, Florian Scotté, (unknown), (unknown), (unknown), Michael Schlander, Valesca P. Retèl, Wim H. van Harten	1
2	Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib 2025 ·npj Breast Cancer ·Sylvain Ladoire, (unknown), Loïck Galland, (unknown), Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhaï, (unknown), Audrey Hennequin, (unknown), Clémentine Jankowski, Charles Coutant, Laurent Arnould, Tienhan Sandrine Dabakuyo‐Yonli	1
3	Traduction et republication de : « Traitement anticoagulant de la maladie veineuse thromboembolique associée au cancer » 2024 ·La Revue de Médecine Interne ·Isabelle Mahé, Didier Mayeur, Françis Couturaud, F. Scotté, Y. Benhamou, (unknown), (unknown), Silvy Laporte, (unknown), Patrick Mismetti, Olivier Sanchez	2
4	Soins oncologiques de support, pratiques non conventionnelles et cancérologie intégrative : de la nécessité d’une clarification 2024 ·Bulletin du Cancer ·(unknown), Didier Mayeur, Philippe Poulain, (unknown), I. Krakowski	0
5	340O Efficacy, safety and biomarker analysis of ICARUS-BREAST01: A phase II study of patritumab deruxtecan (HER3-DXd) in patients (pts) with HR+/HER2- advanced breast cancer (ABC) 2024 ·Annals of Oncology ·Barbara Pistilli, Luisa Pierotti, (unknown), Cécile Vicier, Jean‐Sébastien Frenel, Véronique D’Hondt, (unknown), (unknown), Agnès Ducoulombier, (unknown), (unknown), Didier Mayeur, (unknown), Andrea Sporchia, Fumitaka Suto, Stefan Michiels, (unknown), (unknown), Fabrice André, Guillaume Montagnac	11
6	Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry 2024 ·The Breast ·Sylvain Ladoire, (unknown), Loïck Galland, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhaï, (unknown), Audrey Hennequin, Clémentine Jankowski, Juliette Albuisson, Sophie Nambot, Charles Coutant, Laurent Arnould, (unknown), Caroline Truntzer, Tienhan Sandrine Dabakuyo‐Yonli	1
7	Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience 2024 ·Cancers ·(unknown), (unknown), Pierre Jacob, (unknown), Isabelle Desmoulins, Sylvie Zanetta, Courèche Kaderbhaï, Loïck Galland, Didier Mayeur, Benjamin Delattre, L. Cormier, Sylvain Ladoire	1
8	Treatment of cancer-associated venous thromboembolism in patients under palliative care 2023 ·Archives of cardiovascular diseases ·P. Debourdeau, Marie‐Antoinette Sevestre, Laurent Bertoletti, Didier Mayeur, Philippe Girard, Florian Scotté, Olivier Sanchez, Isabelle Mahé	0
9	Care pathways for patients with cancer-associated thrombosis: From diagnosis to long-term follow-up 2023 ·Archives of cardiovascular diseases ·Marie‐Antoinette Sevestre, (unknown), (unknown), (unknown), (unknown), (unknown), Didier Mayeur, Florian Scotté, Isabelle Mahé, Olivier Sanchez	4
10	PROPERTY: study protocol for a randomized, double-blind, multicenter placebo-controlled trial assessing neurotoxicity in patients with metastatic gastrointestinal cancer taking PHYCOCARE® during oxaliplatin-based chemotherapy 2023 ·Trials ·(unknown), Yann Péréon, Maxime Leroy, Olivier Lépine, (unknown), (unknown), Christelle Volteau, (unknown), (unknown), (unknown), (unknown), (unknown), Caroline Pétorin, (unknown), Catherine Ligeza‐Poisson, Didier Mayeur, Laurent Flet, Anne Chiffoleau, (unknown), Jaafar Bennouna	4
11	Pathologic complete response and survival in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy 2023 ·Breast Cancer ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Laurent Arnould, Françoise Beltjens, (unknown), Didier Mayeur, Courèche Kaderbhaï, Audrey Hennequin, Clémentine Jankowski, (unknown), (unknown), (unknown), Charles Coutant, Bruno Coudert, Aurélie Bertaut, Sylvain Ladoire	8
12	Anticoagulant treatment of cancer-associated thromboembolism 2023 ·Archives of cardiovascular diseases ·Isabelle Mahé, Didier Mayeur, Françis Couturaud, Florian Scotté, Y. Benhamou, (unknown), Laurent Bertoletti, Silvy Laporte, Philippe Girard, Patrick Mismetti, Olivier Sanchez	8
13	189O A phase II study of patritumab deruxtecan (HER3-DXd), in patients (pts) with advanced breast cancer (ABC), with biomarker analysis to characterize response to therapy (ICARUS-BREAST01) 2023 ·ESMO Open ·(unknown), (unknown), (unknown), Véronique D’Hondt, Cécile Vicier, Jean‐Sébastien Frenel, Florence Dalenc, Thomas Bachelot, (unknown), Delphine Loirat, Agnès Ducoulombier, Didier Mayeur, (unknown), (unknown), (unknown), Dalila Sellami, Stefan Michiels, Fabrice André, M.F. Mosele, Guillaume Montagnac	13
14	Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencing 2022 ·npj Breast Cancer ·Loïck Galland, Elise Ballot, (unknown), Romain Boidot, (unknown), Juliette Albuisson, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhaï, (unknown), Audrey Hennequin, (unknown), Valentin Dérangère, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire	14
15	Infection à SARS-CoV-2/COVID 19 et cancers solides : synthèse des recommandations à l’attention des professionnels de santé 2020 ·Bulletin du Cancer ·Thomas Grellety, Alain Ravaud, (unknown), G. Ganem, P. Giraud, Rosine Guimbaud, Laure Kaluzinski, I. Krakowski, Didier Mayeur, Jean‐Pierre Lotz, Benoît You	16
16	French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation 2018 ·Joint Bone Spine ·Karine Briot, Julien Paccou, Philippe Beuzeboc, Jacques Bonneterre, Béatrice Bouvard, Cyrille B. Confavreux, Catherine Cormier, Bernard Cortet, Jean‐Michel Hannoun‐Lévi, Christophe Hennequin, Rose‐Marie Javier, Éric Lespessailles, Didier Mayeur, (unknown), Marie-Hélène Vieillard, Françoise Debiais	27
17	Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study 2012 ·Journal of Clinical Oncology ·Pascale Mariani, Joëlle Blumberg, Alain Landau, (unknown), Estelle Botton, Olivier Béatrix, Didier Mayeur, (unknown), Pascal Maisonobe, L. Chauvenet	37
18	A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α: a prospective randomized controlled trial of the ELYPSE study group 2009 ·Annals of Oncology ·Isabelle Ray‐Coquard, Sophie Dussart, (unknown), Didier Mayeur, P. Debourdeau, Hervé Ghesquières, Thomas Bachelot, A. Le Cesne, Bruno Anglaret, (unknown), Jean‐Paul Guastalla, (unknown), Pierre Biron, Françoise Desseigne, Jean‐Yves Blay	18
19	A Case of Chronic Neutrophilic Leukemia with Deletion (11)(q23) 1999 ·Cancer Genetics and Cytogenetics ·Christine Terré, (unknown), Jean Bastié, Didier Mayeur, (unknown), (unknown), Roland Berger, Sylvie Castaigné	14
20	Subcutaneous recombinant interleukin-2 (rIL-2) in out-patients with metastatic renal cell carcinoma 1996 ·Annals of Oncology ·J.M. Tourani, Virginie Lucas, Didier Mayeur, B Dufour, Mario Di Palma, C Boaziz, P. Grise, C. Varette, (unknown), Éric Pujade-Lauraine, (unknown), (unknown), M. Untereiner, E. Vuillemin, S. Merran, Jean‐Marie Andrieu	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact